CNCharlotte Nachtegael

Charlotte Nachtegael

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Charlotte Nachtegael has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Tom Lenaerts

    Machine Learning Group, Université Libre de Bruxelles, Brussels, Belgium

    6 shared publications
  • Ann Nowé

    Department of Computer Science, Vrije Universiteit Brussel, Brussels, Belgium

    3 shared publications
  • Sofia Papadimitriou

    Interuniversity Institute for Bioinformatics in Brussels, ULB-VUB, 1050 Brussels, Belgium; Machine Learning Group, Université Libre de Bruxelles, 1050 Brussels, Belgium; Artificial Intelligence Lab, Vrije Universiteit Brussel, 1050 Brussels, Belgium

    3 shared publications
  • Andrea Gazzo

    Interuniversity Institute for Bioinformatics in Brussels, ULB-VUB, 1050 Brussels, Belgium; Machine Learning Group, Université Libre de Bruxelles, 1050 Brussels, Belgium; Center for Medical Genetics, Reproduction and Genetics, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, UZ Brussel, 1050 Brussels, Belgium

    2 shared publications
  • Anthony Cnudde

    Machine Learning Group, Université Libre de Bruxelles , Boulevard du Triomphe, CP 212, Brussels 1050, Belgium

    2 shared publications
  • Guillaume Smits

    Interuniversity Institute for Bioinformatics in Brussels, ULB-VUB, 1050 Brussels, Belgium; Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, 1020 Brussels, Belgium; Center for Medical Genetics, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium

    2 shared publications

Latest Publications

  • Open Access

    HDI Corpus: A Dataset for Named Entity Recognition for In-Context Herb-Drug Interactions

    by Anthony Cnudde, Patrick Watrin, Charlotte Nachtegael, Florence Souard

    Introduction: This article proposes a new dataset for Named Entity Recognition based on PubMed articles and aiming to address the problem of Herb-Drug Interactions. It aims to offer a new dataset for recognizing herb-drug interaction entities, including contextual information. Background: Machine learning and Deep learning provide users with powerful tools for task automation, but require large quantities of data to perform well. In the field of Natural Language Processing, training Deep Learning models requires the annotation of large corpora of text. While some corpora exist in medical literature, each specific task requires an adapted corpus. Methods: The dataset was tested using a classical Named Entity Recognition pipeline, as well as new possibilities offered by generative AI. Results: The dataset proposes annotated sentences of around a hundred articles and covers 15 entities, including herbs, drugs, and pathologies, as well as contextual information, such as cohort composition, patient information, or pharmacological clues. Discussion: The study demonstrates that this dataset performs comparably to the DDI (Drug-Drug Interaction) corpus — a standard dataset in the drug Named Entity Recognition — for drug recognition, and performs well on most of the entities. Conclusion : We believe this corpus could help diversify pharmacological Named Entity Recognition.

  • Open Access

    DUVEL: an active-learning annotated biomedical corpus for the recognition of oligogenic combinations

    by Charlotte Nachtegael, Jacopo De Stefani, Anthony Cnudde, Tom Lenaerts

    While biomedical relation extraction (bioRE) datasets have been instrumental in the development of methods to support biocuration of single variants from texts, no datasets are currently available for the extraction of digenic or even oligogenic variant relations, despite the reports in literature that epistatic effects between combinations of variants in different loci (or genes) are important to understand disease etiologies. This work presents the creation of a unique dataset of oligogenic variant combinations, geared to train tools to help in the curation of scientific literature. To overcome the hurdles associated with the number of unlabelled instances and the cost of expertise, active learning (AL) was used to optimize the annotation, thus getting assistance in finding the most informative subset of samples to label. By pre-annotating 85 full-text articles containing the relevant relations from the Oligogenic Diseases Database (OLIDA) with PubTator, text fragments featuring potential digenic variant combinations, i.e. gene–variant–gene–variant, were extracted. The resulting fragments of texts were annotated with ALAMBIC, an AL-based annotation platform. The resulting dataset, called DUVEL, is used to fine-tune four state-of-the-art biomedical language models: BiomedBERT, BiomedBERT-large, BioLinkBERT and BioM-BERT. More than 500 000 text fragments were considered for annotation, finally resulting in a dataset with 8442 fragments, 794 of them being positive instances, covering 95% of the original annotated articles. When applied to gene–variant pair detection, BiomedBERT-large achieves the highest F1 score (0.84) after fine-tuning, demonstrating significant improvement compared to the non-fine-tuned model, underlining the relevance of the DUVEL dataset. This study shows how AL may play an important role in the creation of bioRE dataset relevant for biomedical curation applications. DUVEL provides a unique biomedical corpus focusing on 4-ary relations between two genes and two variants. It is made freely available for research on GitHub and Hugging Face. Database URL: https://huggingface.co/datasets/cnachteg/duvel or https://doi.org/10.57967/hf/1571


  • Open Access

    A study of deep active learning methods to reduce labelling efforts in biomedical relation extraction

    by Charlotte Nachtegael, Jacopo De Stefani, Tom Lenaerts

    Automatic biomedical relation extraction (bioRE) is an essential task in biomedical research in order to generate high-quality labelled data that can be used for the development of innovative predictive methods. However, building such fully labelled, high quality bioRE data sets of adequate size for the training of state-of-the-art relation extraction models is hindered by an annotation bottleneck due to limitations on time and expertise of researchers and curators. We show here how Active Learning (AL) plays an important role in resolving this issue and positively improve bioRE tasks, effectively overcoming the labelling limits inherent to a data set. Six different AL strategies are benchmarked on seven bioRE data sets, using PubMedBERT as the base model, evaluating their area under the learning curve (AULC) as well as intermediate results measurements. The results demonstrate that uncertainty-based strategies, such as Least-Confident or Margin Sampling, are statistically performing better in terms of F1-score, accuracy and precision, than other types of AL strategies. However, in terms of recall, a diversity-based strategy, called Core-set, outperforms all strategies. AL strategies are shown to reduce the annotation need (in order to reach a performance at par with training on all data), from 6% to 38%, depending on the data set; with Margin Sampling and Least-Confident Sampling strategies moreover obtaining the best AULCs compared to the Random Sampling baseline. We show through the experiments the importance of using AL methods to reduce the amount of labelling needed to construct high-quality data sets leading to optimal performance of deep learning models. The code and data sets to reproduce all the results presented in the article are available at https://github.com/oligogenic/Deep_active_learning_bioRE.


  • Open Access

    ALAMBIC : Active Learning Automation Methods to Battle Inefficient Curation

    by Charlotte Nachtegael, Jacopo De Stefani, Tom Lenaerts

    Charlotte Nachtegael, Jacopo De Stefani, Tom Lenaerts. Proceedings of the 17th Conference of the European Chapter of the Association for Computational Linguistics: System Demonstrations. 2023.


  • Open Access

    Scaling up oligogenic diseases research with OLIDA: the Oligogenic Diseases Database

    by Charlotte Nachtegael, Barbara Gravel, Arnau Dillen, Guillaume Smits, Ann Nowé, Sofia Papadimitriou, Tom Lenaerts

    Improving the understanding of the oligogenic nature of diseases requires access to high-quality, well-curated Findable, Accessible, Interoperable, Reusable (FAIR) data. Although first steps were taken with the development of the Digenic Diseases Database, leading to novel computational advancements to assist the field, these were also linked with a number of limitations, for instance, the ad hoc curation protocol and the inclusion of only digenic cases. The OLIgogenic diseases DAtabase (OLIDA) presents a novel, transparent and rigorous curation protocol, introducing a confidence scoring mechanism for the published oligogenic literature. The application of this protocol on the oligogenic literature generated a new repository containing 916 oligogenic variant combinations linked to 159 distinct diseases. Information extracted from the scientific literature is supplemented with current knowledge support obtained from public databases. Each entry is an oligogenic combination linked to a disease, labelled with a confidence score based on the level of genetic and functional evidence that supports its involvement in this disease. These scores allow users to assess the relevance and proof of pathogenicity of each oligogenic combination in the database, constituting markers for reporting improvements on disease-causing oligogenic variant combinations. OLIDA follows the FAIR principles, providing detailed documentation, easy data access through its application programming interface and website, use of unique identifiers and links to existing ontologies. https://olida.ibsquare.be


  • Open Access

    Enhanced processivity of Dnmt1 by monoubiquitinated histone H3

    by Yuichi Mishima, Laura Brueckner, Saori Takahashi, Toru Kawakami, Junji Otani, Akira Shinohara, Kohei Takeshita, Ronald Garingalao Garvilles, Mikio Watanabe, Norio Sakai, et al.

    DNA methylation controls gene expression, and once established, DNA methylation patterns are faithfully copied during DNA replication by the maintenance DNA methyltransferase Dnmt1. In vivo, Dnmt1 interacts with Uhrf1, which recognizes hemimethylated CpGs. Recently, we reported that Uhrf1‐catalyzed K18‐ and K23‐ubiquitinated histone H3 binds to the N‐terminal region (the replication focus targeting sequence, RFTS) of Dnmt1 to stimulate its methyltransferase activity. However, it is not yet fully understood how ubiquitinated histone H3 stimulates Dnmt1 activity. Here, we show that monoubiquitinated histone H3 stimulates Dnmt1 activity toward DNA with multiple hemimethylated CpGs but not toward DNA with only a single hemimethylated CpG, suggesting an influence of ubiquitination on the processivity of Dnmt1. The Dnmt1 activity stimulated by monoubiquitinated histone H3 was additively enhanced by the Uhrf1 SRA domain, which also binds to RFTS. Thus, Dnmt1 activity is regulated by catalysis (ubiquitination)‐dependent and ‐independent functions of Uhrf1.


  • Using game theory and decision decomposition to effectively discern and characterise bi-locus diseases

    by Nassim Versbraegen, Aziz Fouché, Charlotte Nachtegael, Sofia Papadimitriou, Andrea Gazzo, Guillaume Smits, Tom Lenaerts


  • Open Access

    ORVAL: a novel platform for the prediction and exploration of disease-causing oligogenic variant combinations

    by Alexandre Renaux, Sofia Papadimitriou, Nassim Versbraegen, Charlotte Nachtegael, Simon Boutry, Ann Nowé, Guillaume Smits, Tom Lenaerts

    A tremendous amount of DNA sequencing data is being produced around the world with the ambition to capture in more detail the mechanisms underlying human diseases. While numerous bioinformatics tools exist that allow the discovery of causal variants in Mendelian diseases, little to no support is provided to do the same for variant combinations, an essential task for the discovery of the causes of oligogenic diseases. ORVAL (the Oligogenic Resource for Variant AnaLysis), which is presented here, provides an answer to this problem by focusing on generating networks of candidate pathogenic variant combinations in gene pairs, as opposed to isolated variants in unique genes. This online platform integrates innovative machine learning methods for combinatorial variant pathogenicity prediction with visualization techniques, offering several interactive and exploratory tools, such as pathogenic gene and protein interaction networks, a ranking of pathogenic gene pairs, as well as visual mappings of the cellular location and pathway information. ORVAL is the first web-based exploration platform dedicated to identifying networks of candidate pathogenic variant combinations with the sole ambition to help in uncovering oligogenic causes for patients that cannot rely on the classical disease analysis tools. ORVAL is available at https://orval.ibsquare.be.


  • Open Access

    Predicting disease-causing variant combinations

    by Sofia Papadimitriou, Andrea Gazzo, Nassim Versbraegen, Charlotte Nachtegael, Jan Aerts, Yves Moreau, Sonia Van Dooren, Ann Nowé, Guillaume Smits, Tom Lenaerts

    Notwithstanding important advances in the context of single-variant pathogenicity identification, novel breakthroughs in discerning the origins of many rare diseases require methods able to identify more complex genetic models. We present here the Variant Combinations Pathogenicity Predictor (VarCoPP), a machine-learning approach that identifies pathogenic variant combinations in gene pairs (called digenic or bilocus variant combinations). We show that the results produced by this method are highly accurate and precise, an efficacy that is endorsed when validating the method on recently published independent disease-causing data. Confidence labels of 95% and 99% are identified, representing the probability of a bilocus combination being a true pathogenic result, providing geneticists with rational markers to evaluate the most relevant pathogenic combinations and limit the search space and time. Finally, the VarCoPP has been designed to act as an interpretable method that can provide explanations on why a bilocus combination is predicted as pathogenic and which biological information is important for that prediction. This work provides an important step toward the genetic understanding of rare diseases, paving the way to clinical knowledge and improved patient care.


  • The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow

    by Laurence de la Kethulle de Ryhove, Eugénie Ansseau, Charlotte Nachtegael, Karlien Pieters, Céline Vanderplanck, Mieke Geens, Karen D Sermon, Steve D. Wilton, Frédérique Coppée, Laurence Lagneaux, et al.

    Facioscapulohumeral muscular dystrophy (FSHD) is associated with an activation of the double homeobox 4 (DUX4 ) gene, which we previously identified within the D4Z4 repeated elements in the 4q35 subtelomeric region. The pathological DUX4 mRNA is derived from the most distal D4Z4 unit and extends unexpectedly within the flanking pLAM region, which provides an intron and polyadenylation signal. The conditions that are required to develop FSHD are a permissive allele providing the polyadenylation signal and hypomethylation of the D4Z4 repeat array compared with the healthy muscle. The DUX4 protein is a 52-kDa transcription factor that initiates a large gene deregulation cascade leading to muscle atrophy, inflammation, differentiation defects, and oxidative stress, which are the key features of FSHD. DUX4 is a retrogene that is normally expressed in germline cells and is submitted to repeat-induced silencing in adult tissues. Since DUX4 mRNAs have been detected in human embryonic and induced pluripotent stem cells, we investigated whether they could also be expressed in human mesenchymal stromal cells (hMSCs). We found that DUX4 mRNAs were induced during the differentiation of hMSCs into osteoblasts and that this process involved DUX4 and new longer protein forms (58 and 70 kDa). A DUX4 mRNA with a more distant 5′ start site was characterized that presented a 60-codon reading frame extension and encoded the 58-kDa protein. Transfections of hMSCs with an antisense oligonucleotide targeting DUX4 mRNAs decreased both the 52- and 58-kDa protein levels and confirmed their identity. Gain- and loss-of-function experiments in hMSCs suggested these DUX4 proteins had opposite roles in osteogenic differentiation as evidenced by the alkaline phosphatase activity and calcium deposition. Differentiation was delayed by the 58-kDa DUX4 expression and it was increased by 52-kDa DUX4. These data indicate a role for DUX4 protein forms in the osteogenic differentiation of hMSCs.